Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Guidelines for cardiovascular risk assessment and cholesterol treatment.

Lloyd-Jones DM, Goff DC Jr, Stone NJ.

JAMA. 2014 Jun 4;311(21):2235. doi: 10.1001/jama.2014.4072. No abstract available.

PMID:
24893098
2.

Guidelines for cardiovascular risk assessment and cholesterol treatment--reply.

Montori VM, Brito JP, Ting HH.

JAMA. 2014 Jun 4;311(21):2236. doi: 10.1001/jama.2014.4078. No abstract available.

PMID:
24893100
3.

Guidelines for cardiovascular risk assessment and cholesterol treatment--reply.

Ioannidis JP.

JAMA. 2014 Jun 4;311(21):2235-6. doi: 10.1001/jama.2014.4075. No abstract available.

PMID:
24893099
4.

Aronow's "Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?" Commentary.

Mooradian AD.

J Gerontol A Biol Sci Med Sci. 2005 May;60(5):598; author reply 602. No abstract available.

PMID:
16094774
5.

Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?

Aronow WS.

J Gerontol A Biol Sci Med Sci. 2005 May;60(5):591-2. No abstract available.

PMID:
15972605
6.

New Reports May Help Resolve the Conflict on Cholesterol Treatment Guidelines.

Wallis L.

Am J Nurs. 2015 Oct;115(10):16. doi: 10.1097/01.NAJ.0000471927.85804.ea.

PMID:
26402274
7.

Aronow's "Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?" Commentary.

Levy DR, Pearson TA.

J Gerontol A Biol Sci Med Sci. 2005 May;60(5):597-8; author reply 602. No abstract available.

PMID:
16094772
8.
9.

Aronow's "Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?" Aim low.

Nash IS.

J Gerontol A Biol Sci Med Sci. 2005 May;60(5):599-600; author reply 602. No abstract available.

PMID:
15972609
10.
11.

New statin guidelines: do they apply to you?

[No authors listed]

Harv Health Lett. 2014 Feb;39(4):8. No abstract available.

PMID:
24669404
12.
13.

Stricter cholesterol guidelines broaden indications for the 'statin' drugs.

Capriotti T.

Medsurg Nurs. 2003 Feb;12(1):51-7. Review. No abstract available.

PMID:
12619600
14.

New cholesterol guidelines and the secondary prevention of cardiovascular disease - a commentary on epistemic aspects.

Nunes JP.

Prev Med. 2014 Dec;69:314-6. doi: 10.1016/j.ypmed.2014.06.035. Epub 2014 Aug 13.

PMID:
25128714
15.

The primary target. Taking aim at LDL levels to prevent cardiovascular disease.

Mason CM.

Adv Nurse Pract. 2007 Dec;15(12):55-8. No abstract available.

PMID:
20014676
16.

Don't trust an LDL over 70?

Aronow WS.

Geriatrics. 2004 May;59(5):12-3. No abstract available.

PMID:
15152729
17.

Achieving lipid goals. A study of outcomes in an NP Clinic.

Adkins J, Stanley M.

Adv Nurse Pract. 2007 Jun;15(6):61-2, 64. No abstract available.

PMID:
19999011
18.

Aronow's "Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?" What do we do for the very old?

Goodwin JS.

J Gerontol A Biol Sci Med Sci. 2005 May;60(5):593-594; author reply 602. No abstract available.

PMID:
15972606
19.

Alice in lipidland: the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol.

Wenger NK.

J Am Coll Cardiol. 2014 Dec 2;64(21):2193-5. doi: 10.1016/j.jacc.2014.08.040. Epub 2014 Nov 19. No abstract available.

20.

2013 ACC/AHA guideline on the treatment of blood cholesterol: a fresh interpretation of old evidence.

Psaty BM, Weiss NS.

JAMA. 2014 Feb 5;311(5):461-2. doi: 10.1001/jama.2013.284203. No abstract available.

PMID:
24264722

Supplemental Content

Support Center